Alerts

New Basal Insulin Approved. See the Product of the Week. New Test Approved to Diagnose Type 1 Diabetes. See this week’s Facts.

First SGLT-2 + Metformin Approved See this week’s Item #1.

Diabetes Drug Empagliflozin (Jardiance- SGLT-2) Wins FDA Approval. More news in next week’s issue. GSK’s Tanzeum (GLP-1 agonist) is now available in pharmacies in the U.S.

Novartis and Google Developing Smart Contact Lens to Monitor Blood Sugars See this week’s Item #11. 

FDA accepts application for Sanofi’s New Basal Insulin, Toujeo 

Afrezza Approved in U.S. For more details, see item#1.

FDA Approves Inhaled Insulin Afrezza for Diabetes. MannKind Corporation today announced that the FDA has approved AFREZZA® (insulin human) Inhalation Powder to improve glycemic control in adult patients with diabetes mellitus. More news to come. Bionic Pancreas Effective for Type 1’s. See this week’s Item #9.

A1c Goals Lowered for Children with Type 1 Diabetes See this week’s Item #1.

Watch for our upcoming issue focusing on the 74th American Diabetes Association Scientific Sessions.

JAMA to report next week that insulin as a second medication may cause harm. Information embargoed until next week.